Diabetes Control Flashcards
Glyburide
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
SE: hypoglycemia, weight gain
Glipizide
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
SE: hypoglycemia, weight gain
Glimepiride
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
SE: hypoglycemia, weight gain
- Tolbutamide
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
- Chlorpropramide
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
Repaglinide, Nateglinide
sulfonylurea, oral hypoglycemic;
Mech: close beta cell K+-ATP channels = stimulate insulin.
Use: DM2
SE: hypoglycemia, weight gain
Metformin
potent insulin sensitizer;
Mech: increase glucose uptake, suppress endog. glucose production
Use: DM2 (#1 drug to start with!), often in combo
SE: diarrhea, lactic acidosis
Contraind: renal/liver failure, hypotension
Pioglitazone, Rosiglitazone
PPAR-g agonists, insulin sensitizers;
Mech: alter gene transcription = increase fat cell diff.
Use: DM2
SE: edema, weight gain, CHF, osteoporisis, CV events
Acarbose, Miglitol
a-glucosidase inhibitor, *low potency
=> inhibit carb metab = delay absorption
Use: DM2
SE: GI
Colesevelam
Bile acid sequestrant, hypoglycemic;
Mech: unknown, up-regulate LDL R
Use: DM2
SE: GI (constipation, bloating)
Exenatide, Lyraglutide
GLP-1 analog (Incretin);
=> increase insulin/decrease glucagon secretion, + CNS satiety
Use: DM2 (*injection)
SE: pancreatitis (rare), nausea
x Canagliflozin
SGLT-2 (Na-Glucose transporter) inhibitor;
=> decerase glucose reabsorption @ kidney
Use: DM2
SE: yeast inf./UTI, hypotension/hypovolemia
x Bromocriptine mesylate
D2 (dopamine) agonist, *ergot deriv.;
=> increase insulin sensitivity & glucose tolerance via CNS.
Use: DM2, hyperprolactinemia, acromegaly
SE: orthostatic hypotension, headache, digital vasospasm
Pramlintide
amylin analog (synthetic),
=> via CNS: slow gastric emptying & reduce glucagon secretion
Use: DM2
SE: hypoglycemia (need to decrease premeal insulin dose!)
Sitagliptin, Linagliptin, Saxagliptin, Vidagliptin
“DPP-4” (dipeptyl Peptidase 4) inhibitors,
–l degradation of GLP-1 & endog. incretins
Use: DM2, low potency
* Few SEs